Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Atossa Therapeutics Inc (ATOS)

Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Atossa Therapeutics to Present Poster on (Z)-Endoxifen at AACR Special Conference in Cancer Research GlobeNewswire - 42 minutes ago

ATOS : 1.1900 (-0.83%)
Atossa Therapeutics Announces Five Abstracts Accepted for Presentation at SABCS 2024 Featuring (Z)-Endoxifen Data in Breast Cancer Research Quiver Quantitative, Inc. - Wed Nov 20, 5:52PM CST

Atossa Therapeutics announced five accepted abstracts on (Z)-endoxifen for the San Antonio Breast Cancer Symposium in December 2024.Quiver AI SummaryAtossa Therapeutics, a clinical-stage biopharmaceutical...

ATOS : 1.1900 (-0.83%)
Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium GlobeNewswire - Wed Nov 20, 7:30AM CST

ATOS : 1.1900 (-0.83%)
Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Tue Nov 12, 7:30AM CST

ATOS : 1.1900 (-0.83%)
Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product Development GlobeNewswire - Tue Nov 5, 7:30AM CST

ATOS : 1.1900 (-0.83%)
Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results: GlobeNewswire - Mon Nov 4, 5:30AM CST

ATOS : 1.1900 (-0.83%)
Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer GlobeNewswire - Thu Oct 31, 7:15AM CDT

ATOS : 1.1900 (-0.83%)
Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer GlobeNewswire - Mon Oct 21, 7:30AM CDT

ATOS : 1.1900 (-0.83%)
Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women Newswire.ca - Tue Oct 15, 6:32AM CDT

/CNW/ -- With every October, breast cancer awareness surges thanks to very effective campaigns and new developments in breast cancer treatment. However, this...

ONCY : 1.0300 (+3.15%)
HOLX : 78.04 (-0.67%)
KZIA : 5.61 (-1.75%)
ATOS : 1.1900 (-0.83%)
NVS : 103.28 (+0.18%)
ONC.TO : 1.40 (-5.41%)
KZA.AX : 0.080 (+9.59%)
Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit GlobeNewswire - Mon Oct 14, 4:08PM CDT

ATOS : 1.1900 (-0.83%)

Barchart Exclusives

Is Apple Stock a Buy Now, or Should You Wait for a Dip? Barchart - 6 minutes ago
Apple stock has underperformed markets in 2024. It might be worthwhile waiting for a dip in AAPL stock instead of rushing to buy at current price levels. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot